Dextran antibodies in peritoneal dialysis patients treated with icodextrin.
D000906:Antibodies / Q000097:blood* / Q000276:immunology; D000925:Anticoagulants / Q000097:blood* / Q000276:immunology; D003911:Dextrans / Q000097:blood* / Q000276:immunology; D015314:Dialysis Solutions / Q000009:adverse effects*; D005076:Exanthema / Q000097:blood* / Q000139:chemically induced* / Q000276:immunology; D005936:Glucans / Q000009:adverse effects* / Q000276:immunology; D005947:Glucose / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D000077607:Icodextrin; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000276:immunology / Q000628:therapy*; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000097:blood* / Q000139:chemically induced* / Q000276:immunology; D013997:Time Factors
D000906:Antibodies; D000925:Anticoagulants; D003911:Dextrans; D015314:Dialysis Solutions; D005936:Glucans; D000077607:Icodextrin; D005947:Glucose